Current Status and Advances in Pancreatic Cancer Therapeutics and Diagnostic
Pancreatic cancer remains one of the deadliest cancers with a 5-year survival rate of only around 9% (American Cancer Society, 2020). This is mainly due …
Unleashing Industry Insights, Connecting the Future
Pancreatic cancer remains one of the deadliest cancers with a 5-year survival rate of only around 9% (American Cancer Society, 2020). This is mainly due …
Burden of Acinetobacter Pneumonia Therapeutics Industry Acinetobacter baumannii is a gram-negative bacterium that is an emerging cause of hospital-acquired and ventilator-associated pneumonia worldwide. It has …
Novel Approaches in Antibiotic Development The emergence of antibiotic resistance has posed a serious threat in recent decades. While many “superbugs” have developed resistance …
Over the past few decades, our understanding of human biology has advanced tremendously due to breakthroughs in modern technology and genomic research. Scientists now have …
Pancreatic cancer is one of the deadliest cancers with a low survival rate. However, ongoing research and developments in therapeutics and diagnostics promise better outcomes …
Recombinant DNA technology involves the insertion of a foreign DNA into a host organism allowing it to produce new substances. It is used in gene …
Stanford chemists have made a breakthrough in understanding how proteins are degraded within cells, leading to promising new possibilities for therapeutic interventions. By targeting proteins …
New research published in Nature Nanotechnology may have found a solution to mitigate the negative side effects associated with the intravenous injection of nanoparticles commonly …